GPR55 – a putative “type 3” cannabinoid receptor in inflammation
G protein-coupled receptor 55 (GPR55) shares numerous cannabinoid ligands with CB1 and CB2 receptors despite low homology with those classical cannabinoid receptors. The pharmacology of GPR55 is not yet fully elucidated; however, GPR55 utilizes a different signaling system and downstream cascade ass...
Saved in:
| Published in | Journal of basic and clinical physiology and pharmacology Vol. 27; no. 3; pp. 297 - 302 |
|---|---|
| Main Authors | , , |
| Format | Journal Article |
| Language | English |
| Published |
Berlin
De Gruyter
01.05.2016
Walter de Gruyter GmbH |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | G protein-coupled receptor 55 (GPR55) shares numerous cannabinoid ligands with CB1 and CB2 receptors despite low homology with those classical cannabinoid receptors. The pharmacology of GPR55 is not yet fully elucidated; however, GPR55 utilizes a different signaling system and downstream cascade associated with the receptor. Therefore, GPR55 has emerged as a putative “type 3” cannabinoid receptor, establishing a novel class of cannabinoid receptor. Furthermore, the recent evidence of GPR55-CB1 and GPR55-CB2 heteromerization along with its broad distribution from central nervous system to peripheries suggests the importance of GPR55 in various cellular processes and pathologies and as a potential therapeutic target in inflammation. |
|---|---|
| AbstractList | G protein-coupled receptor 55 (GPR55) shares numerous cannabinoid ligands with CB1 and CB2 receptors despite low homology with those classical cannabinoid receptors. The pharmacology of GPR55 is not yet fully elucidated; however, GPR55 utilizes a different signaling system and downstream cascade associated with the receptor. Therefore, GPR55 has emerged as a putative "type 3" cannabinoid receptor, establishing a novel class of cannabinoid receptor. Furthermore, the recent evidence of GPR55-CB1 and GPR55-CB2 heteromerization along with its broad distribution from central nervous system to peripheries suggests the importance of GPR55 in various cellular processes and pathologies and as a potential therapeutic target in inflammation. Abstract G protein-coupled receptor 55 (GPR55) shares numerous cannabinoid ligands with CB1 and CB2 receptors despite low homology with those classical cannabinoid receptors. The pharmacology of GPR55 is not yet fully elucidated; however, GPR55 utilizes a different signaling system and downstream cascade associated with the receptor. Therefore, GPR55 has emerged as a putative “type 3” cannabinoid receptor, establishing a novel class of cannabinoid receptor. Furthermore, the recent evidence of GPR55-CB1 and GPR55-CB2 heteromerization along with its broad distribution from central nervous system to peripheries suggests the importance of GPR55 in various cellular processes and pathologies and as a potential therapeutic target in inflammation. |
| Author | Yang, Hyewon Zhou, Juan Lehmann, Christian |
| Author_xml | – sequence: 1 givenname: Hyewon surname: Yang fullname: Yang, Hyewon – sequence: 2 givenname: Juan surname: Zhou fullname: Zhou, Juan – sequence: 3 givenname: Christian surname: Lehmann fullname: Lehmann, Christian email: chlehmann@mac.com |
| BookMark | eNptkMFKw0AQhhepYK09ew14jp3dzexuDh6k2CoUFNHzskk3ktJu4iZRcus7eNWX65O4tR48OAzMDPz_P_CdkoGrnCXknMIlRYqTVZbXdcyAYgyg4IgMGU1pDEyJARmCTFksFOIJGTfNCkIlKUWZDsls_vCIGO22H5GJ6q41bflmw_nZ9rWN-G77FeXGOZOVriqXkbe5rdvKR6ULXazNZhMclTsjx4VZN3b8O0fkeXbzNL2NF_fzu-n1Is65VDJOs8yAyJiQiNYaUCrhhidpooBbwYxgiiOKnDEqREIVZLLIGFgjzBIwiEfk4pBb--q1s02rV1XnXXipqVQKlURFg2pyUOW-ahpvC137cmN8rynoPS_9w0vveek9r-C4Ojjezbq1fmlffNeH5U_8_04mOUsl_wYb9XRW |
| CitedBy_id | crossref_primary_10_1007_s12016_020_08829_y crossref_primary_10_1016_j_ejphar_2020_173738 crossref_primary_10_3389_fphar_2019_00821 crossref_primary_10_3390_ijms25126402 crossref_primary_10_1007_s11938_016_0111_1 crossref_primary_10_1007_s40262_019_00841_6 crossref_primary_10_61186_phypha_27_2_100 crossref_primary_10_1016_j_pharmthera_2020_107529 crossref_primary_10_1016_j_pnpbp_2022_110636 crossref_primary_10_3389_fphar_2016_00264 crossref_primary_10_1074_jbc_RA120_015278 crossref_primary_10_3390_ijms22158168 crossref_primary_10_1177_20406223221143239 crossref_primary_10_3390_ijms242115829 crossref_primary_10_1016_j_intimp_2018_09_006 crossref_primary_10_3390_molecules26185668 crossref_primary_10_3390_cosmetics8030085 crossref_primary_10_1038_ni_3799 crossref_primary_10_1177_09603271221099598 crossref_primary_10_1016_j_bcp_2019_08_025 crossref_primary_10_21307_ane_2018_001 crossref_primary_10_3390_ijms241914677 crossref_primary_10_1089_can_2024_0011 crossref_primary_10_3390_molecules23071526 crossref_primary_10_1016_j_cbi_2018_07_018 crossref_primary_10_1016_j_alcohol_2018_05_008 crossref_primary_10_1016_j_pharmthera_2020_107495 crossref_primary_10_4199_C00151ED1V01Y201702ISP074 crossref_primary_10_3390_cancers13051064 crossref_primary_10_33988_auvfd_1121234 crossref_primary_10_1139_cjpp_2016_0346 crossref_primary_10_3389_fphar_2022_869606 crossref_primary_10_1096_fj_201800171R crossref_primary_10_3390_cells11244102 crossref_primary_10_1002_cpt_568 crossref_primary_10_1186_s12974_018_1362_7 crossref_primary_10_3390_molecules28010106 crossref_primary_10_1016_j_pnpbp_2024_111029 crossref_primary_10_1155_2020_3605153 crossref_primary_10_3389_fvets_2019_00313 crossref_primary_10_1016_j_biopha_2022_113993 crossref_primary_10_2329_perio_63_11 crossref_primary_10_3390_ph16081149 crossref_primary_10_1007_s00280_017_3257_1 crossref_primary_10_1002_cmdc_202000310 crossref_primary_10_1089_can_2017_0031 crossref_primary_10_1016_j_bcp_2022_115398 crossref_primary_10_3389_fphar_2020_596572 crossref_primary_10_1515_jbcpp_2016_0045 crossref_primary_10_3390_biology12060805 crossref_primary_10_3390_ijms22052503 crossref_primary_10_1002_syn_22246 crossref_primary_10_3233_CH_189320 crossref_primary_10_1615_JEnvironPatholToxicolOncol_2022040055 crossref_primary_10_1016_j_lfs_2022_120596 crossref_primary_10_3389_fendo_2020_00103 crossref_primary_10_3390_ijms23158428 crossref_primary_10_1089_can_2020_0179 crossref_primary_10_3389_fphar_2020_00628 crossref_primary_10_1111_bph_13580 crossref_primary_10_1111_bph_14387 crossref_primary_10_1038_s41598_021_93755_y crossref_primary_10_3390_v11060549 crossref_primary_10_3390_molecules26247643 crossref_primary_10_1002_hipo_22747 crossref_primary_10_3390_ph17060674 crossref_primary_10_1016_j_pharmthera_2024_108649 crossref_primary_10_1089_can_2016_0030 crossref_primary_10_1016_j_pbb_2019_03_006 crossref_primary_10_1089_can_2022_0006 |
| Cites_doi | 10.1210/me.2011-1197 10.1093/jb/mvn136 10.1111/j.1365-2982.2011.01742.x 10.1016/S0169-328X(98)00277-0 10.1038/sj.bjp.0707460 10.1083/jcb.200305129 10.3389/fnbeh.2012.00009 10.1074/jbc.M114.561761 10.1016/j.tips.2011.01.005 10.1038/sj.bjp.0707527 10.1016/j.tips.2008.12.004 10.1111/bph.12907 10.1016/j.coph.2012.09.009 10.1016/j.pharmthera.2004.11.005 10.1038/365061a0 10.1074/jbc.M109.050187 10.1038/cr.2011.60 10.1038/384083a0 10.1021/jm800311k 10.1111/j.1476-5381.2009.00625.x 10.1016/j.neuropharm.2013.03.029 10.1016/j.bcp.2011.05.004 10.1371/journal.pone.0089566 10.1016/0006-2952(95)00109-D 10.1093/intimm/dxu097 10.1038/346561a0 10.1016/S0306-4522(97)00436-3 10.1016/j.phrs.2009.02.010 10.1124/pr.54.2.161 10.1096/fj.08-108670 10.1038/sj.ijo.0803272 10.1016/j.cbpa.2009.04.615 10.1021/ja01062a046 10.1126/science.1470919 10.1016/j.pain.2008.04.006 10.1074/jbc.M306642200 10.1016/j.pharmthera.2010.02.004 10.1038/nchembio.129 10.1111/bph.12850 10.1054/plef.2001.0340 10.1016/j.chemphyslip.2010.12.003 10.1074/jbc.272.43.27218 10.1124/pr.58.3.2 10.1021/jm4005175 10.1074/jbc.M112.364109 |
| ContentType | Journal Article |
| Copyright | Copyright Walter de Gruyter GmbH 2016 |
| Copyright_xml | – notice: Copyright Walter de Gruyter GmbH 2016 |
| DBID | AAYXX CITATION 3V. 7RV 7X7 7XB 88E 8AO 8FI 8FJ 8FK ABUWG AFKRA BENPR CCPQU FYUFA GHDGH K9. KB0 M0S M1P NAPCQ PQEST PQQKQ PQUKI PRINS |
| DOI | 10.1515/jbcpp-2015-0080 |
| DatabaseName | CrossRef ProQuest Central (Corporate) ProQuest Nursing & Allied Health Database ProQuest Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central ProQuest Central ProQuest One Community College Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) Nursing & Allied Health Premium ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China |
| DatabaseTitle | CrossRef ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Pharma Collection ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central Nursing & Allied Health Premium ProQuest Health & Medical Complete Health Research Premium Collection ProQuest Medical Library ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest Medical Library (Alumni) ProQuest Central (Alumni) |
| DatabaseTitleList | ProQuest One Academic Eastern Edition CrossRef |
| Database_xml | – sequence: 1 dbid: 7X7 name: ProQuest Health & Medical Collection url: https://search.proquest.com/healthcomplete sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Pharmacy, Therapeutics, & Pharmacology |
| EISSN | 2191-0286 |
| EndPage | 302 |
| ExternalDocumentID | 4054880941 10_1515_jbcpp_2015_0080 10_1515_jbcpp_2015_0080273297 |
| GroupedDBID | 0R~ 0~D 3V. 4.4 53G 5GY 7RV 7X7 88E 8AO 8FI 8FJ AAAEU AABBZ AAEMA AAFPC AAGVJ AALGR AAONY AAOQK AAOWA AAPJK AAQCX AASQH AAWFC AAXCG ABAOT ABAQN ABFKT ABFQV ABIQR ABMIY ABPLS ABRDF ABRQL ABUVI ABUWG ABXMZ ABYBW ACEFL ACGFS ACMKP ACTFP ACXLN ACZBO ADALX ADBBV ADDWE ADEQT ADGQD ADGYE ADOZN AEDGQ AEGVQ AEICA AEJTT AEKEB AEQDQ AERZL AEXIE AFBAA AFBQV AFCXV AFGDO AFGNR AFKRA AFQUK AFYRI AHMBA AHOVO AHVWV AHXUK AIERV AIGSN AIKXB AJATJ AJHHK ALMA_UNASSIGNED_HOLDINGS ALUKF AMAVY ASYPN AZMOX BAKPI BBAFP BBCWN BCIFA BENPR BKEYQ BPHCQ BVXVI BWHEM CGQUA DBYYV EBS EJD EMOBN F5P FSTRU FYUFA HZ~ IY9 M1P NAPCQ O9- PQEST PQQKQ PQUKI PRINS PROAC PSQYO QD8 RDG SA. UKHRP WTRAM AAILP AAYXX ABJNI ABVMU ABWLS ACPMA AGBEV AKXKS ALIPV ALYBR CCPQU CITATION HMCUK KDIRW SLJYH UK5 7XB 8FK K9. |
| ID | FETCH-LOGICAL-c3787-9bba06b26755eea08843a3494803e62a6283556c221664180b7fb20ea6ad05843 |
| IEDL.DBID | 7X7 |
| ISSN | 0792-6855 |
| IngestDate | Thu Oct 10 19:01:23 EDT 2024 Thu Sep 12 19:14:28 EDT 2024 Fri Nov 25 00:40:29 EST 2022 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 3 |
| Language | English |
| License | This content is free. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c3787-9bba06b26755eea08843a3494803e62a6283556c221664180b7fb20ea6ad05843 |
| OpenAccessLink | http://www.degruyter.com/doi/10.1515/jbcpp-2015-0080 |
| PQID | 1788587581 |
| PQPubID | 2031338 |
| PageCount | 6 |
| ParticipantIDs | proquest_journals_1788587581 crossref_primary_10_1515_jbcpp_2015_0080 walterdegruyter_journals_10_1515_jbcpp_2015_0080273297 |
| PublicationCentury | 2000 |
| PublicationDate | 2016-5-1 |
| PublicationDateYYYYMMDD | 2016-05-01 |
| PublicationDate_xml | – month: 05 year: 2016 text: 2016-5-1 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | Berlin |
| PublicationPlace_xml | – name: Berlin |
| PublicationTitle | Journal of basic and clinical physiology and pharmacology |
| PublicationYear | 2016 |
| Publisher | De Gruyter Walter de Gruyter GmbH |
| Publisher_xml | – name: De Gruyter – name: Walter de Gruyter GmbH |
| References | Long, JZ; Li, W; Booker, L; Burston, JJ; Kinsey, SG; Schlosburg, JE (j_jbcpp-2015-0080_ref_015) 2009; 5 Matsuda, LA; Lolait, SJ; Brownstein, MJ; Young, AC; Bonner, TI (j_jbcpp-2015-0080_ref_018) 1990; 346 Ligresti, A; Petrosino, S; Di Marzo, V (j_jbcpp-2015-0080_ref_001) 2009; 13 Henstridge, CM; Balenga, NA; Kargl, J; Andradas, C; Brown, AJ; Irving, A (j_jbcpp-2015-0080_ref_026) 2011; 25 Rempel, V; Volz, N; Gläser, F (j_jbcpp-2015-0080_ref_030) 2013; 56 Li, K; Fichna, J; Schicho, R; Saur, D; Bashashati, M; Mackie, K (j_jbcpp-2015-0080_ref_040) 2013; 71 Bisogno, T; Howell, F; Williams, G; Minassi, A; Cascio, MG; Ligresti, A (j_jbcpp-2015-0080_ref_012) 2003; 163 Balenga, NA; Aflaki, E; Kargl, J; Platzer, W; Schröder, R; Blättermann, S (j_jbcpp-2015-0080_ref_043) 2011; 21 Devane, WA; Hanus, L; Breuer, A; Pertwee, RG; Stevenson, LA; Griffin, G (j_jbcpp-2015-0080_ref_009) 1992; 258 Cravatt, BF; Giang, DK; Mayfield, SP; Boger, DL; Lerner, RA; Gilula, NB (j_jbcpp-2015-0080_ref_013) 1996; 384 Howlett, AC; Barth, F; Bonner, TI; Cabral, G; Casellas, P; Devane, WA (j_jbcpp-2015-0080_ref_022) 2002; 54 Begg, M; Pacher, P; Bátkai, S; Osei-Hyiaman, D; Offertáler, L; Mo, FM (j_jbcpp-2015-0080_ref_023) 2005; 106 Sawzdargo, M; Nguyen, T; Lee, DK; Lynch, KR; Cheng, R; Heng, HHQ (j_jbcpp-2015-0080_ref_025) 1999; 64 Henstridge, CM; Balenga, NA; Ford, LA; Ross, RA; Waldhoer, M; Irving, AJ (j_jbcpp-2015-0080_ref_029) 2009; 23 Moreno, E; Andradas, C; Medrano, M; Caffarel, MM; Pérez-Gómez, E; Blasco-Benito, S (j_jbcpp-2015-0080_ref_037) 2014; 289 Kargl, J; Balenga, N; Parzmair, GP; Brown, AJ; Heinemann, A; Waldhoer, M (j_jbcpp-2015-0080_ref_036) 2012; 287 Pacher, P; Batkai, S; Kunos, G (j_jbcpp-2015-0080_ref_004) 2006; 58 Okamoto, Y; Morishita, J; Tsuboi, K; Tonai, T; Ueda, N (j_jbcpp-2015-0080_ref_011) 2004; 279 Battista, N; Di Tommaso, M; Bari, M; Maccarrone, M (j_jbcpp-2015-0080_ref_005) 2012; 6 Chiurchiù, V; Lanuti, M; De Bardi, M; Battistini, L; Maccarrone, M (j_jbcpp-2015-0080_ref_045) 2015; 27 Cantarella, G; Scollo, M; Lempereur, L; Saccani-Jotti, G; Basile, F; Bernardini, R (j_jbcpp-2015-0080_ref_044) 2011; 82 Mechoulam, R; Ben-Shabat, S; Hanus, L; Ligumsky, M; Kaminski, NE; Schatz, AR (j_jbcpp-2015-0080_ref_010) 1995; 50 Munro, S; Thomas, KL; Abu-Shaar, M (j_jbcpp-2015-0080_ref_019) 1993; 365 Gaoni, Y; Mechoulam, R (j_jbcpp-2015-0080_ref_007) 1964; 86 Kotsikorou, E; Lynch, DL; Abood, ME; Reggio, PH (j_jbcpp-2015-0080_ref_031) 2011; 164 Schicho, R; Storr, M (j_jbcpp-2015-0080_ref_039) 2012; 12 Pertwee, RG (j_jbcpp-2015-0080_ref_006) 2006; 30 Mechoulam, R (j_jbcpp-2015-0080_ref_008) 2002; 66 Seierstad, M; Breitenbucher, JG (j_jbcpp-2015-0080_ref_016) 2008; 51 Ross, RA (j_jbcpp-2015-0080_ref_032) 2009; 30 Ross, RA (j_jbcpp-2015-0080_ref_027) 2011; 32 Lin, XH; Yuece, B; Li, YY; Feng, YJ; Feng, JY; Yu, LY (j_jbcpp-2015-0080_ref_041) 2011; 23 Henstridge, CM; Balenga, NA; Schröder, R; Kargl, JK; Platzer, W; Martini, L (j_jbcpp-2015-0080_ref_033) 2010; 160 Kapur, A; Zhao, P; Sharir, H; Bai, Y; Caron, MG; Barak, LS (j_jbcpp-2015-0080_ref_034) 2009; 284 Oka, S; Toshida, T; Maruyama, K; Nakajima, K; Yamashita, A; Sugiura, T (j_jbcpp-2015-0080_ref_028) 2009; 145 McPartland, JM; Guy, GW; Di Marzo, V (j_jbcpp-2015-0080_ref_003) 2014; 9 Balenga, NA; Martínez-Pinilla, E; Kargl, J; Schröder, R; Peinhaupt, M; Platzer, W (j_jbcpp-2015-0080_ref_038) 2014; 171 Borrelli, F; Romano, B; Petrosino, S; Pagano, E; Capasso, R; Coppola, D (j_jbcpp-2015-0080_ref_046) 2015; 172 Sharir, H; Abood, ME (j_jbcpp-2015-0080_ref_035) 2010; 126 Ryberg, E; Larsson, N; Sjögren, S; Hjorth, S; Hermansson, NO; Leonova, J (j_jbcpp-2015-0080_ref_024) 2007; 152 Di Marzo, V (j_jbcpp-2015-0080_ref_002) 2009; 60 Devane, WA; Dysarz, FA 3rd; Johnson, MR; Melvin, LS; Howlett, AC (j_jbcpp-2015-0080_ref_017) 1988; 34 Karlsson, M; Contreras, JA; Hellman, U; Tornqvist, H; Holm, C (j_jbcpp-2015-0080_ref_014) 1997; 272 Buckley, NE (j_jbcpp-2015-0080_ref_021) 2008; 153 Tsou, K; Brown, S; Sañudo-Peña, MC; Mackie, K; Walker, JM (j_jbcpp-2015-0080_ref_020) 1998; 83 Staton, PC; Hatcher, JP; Walker, DJ; Morrison, AD; Shapland, EM; Hughes, JP (j_jbcpp-2015-0080_ref_042) 2008; 139 2023103015003052659_j_jbcpp-2015-0080_ref_024_w2aab2b8c35b1b7b1ab2ac24Aa 2023103015003052659_j_jbcpp-2015-0080_ref_033_w2aab2b8c35b1b7b1ab2ac33Aa 2023103015003052659_j_jbcpp-2015-0080_ref_015_w2aab2b8c35b1b7b1ab2ac15Aa 2023103015003052659_j_jbcpp-2015-0080_ref_004_w2aab2b8c35b1b7b1ab2ab4Aa 2023103015003052659_j_jbcpp-2015-0080_ref_046_w2aab2b8c35b1b7b1ab2ac46Aa 2023103015003052659_j_jbcpp-2015-0080_ref_037_w2aab2b8c35b1b7b1ab2ac37Aa 2023103015003052659_j_jbcpp-2015-0080_ref_019_w2aab2b8c35b1b7b1ab2ac19Aa 2023103015003052659_j_jbcpp-2015-0080_ref_028_w2aab2b8c35b1b7b1ab2ac28Aa 2023103015003052659_j_jbcpp-2015-0080_ref_020_w2aab2b8c35b1b7b1ab2ac20Aa 2023103015003052659_j_jbcpp-2015-0080_ref_003_w2aab2b8c35b1b7b1ab2ab3Aa 2023103015003052659_j_jbcpp-2015-0080_ref_011_w2aab2b8c35b1b7b1ab2ac11Aa 2023103015003052659_j_jbcpp-2015-0080_ref_008_w2aab2b8c35b1b7b1ab2ab8Aa 2023103015003052659_j_jbcpp-2015-0080_ref_042_w2aab2b8c35b1b7b1ab2ac42Aa 2023103015003052659_j_jbcpp-2015-0080_ref_014_w2aab2b8c35b1b7b1ab2ac14Aa 2023103015003052659_j_jbcpp-2015-0080_ref_007_w2aab2b8c35b1b7b1ab2ab7Aa 2023103015003052659_j_jbcpp-2015-0080_ref_045_w2aab2b8c35b1b7b1ab2ac45Aa 2023103015003052659_j_jbcpp-2015-0080_ref_036_w2aab2b8c35b1b7b1ab2ac36Aa 2023103015003052659_j_jbcpp-2015-0080_ref_018_w2aab2b8c35b1b7b1ab2ac18Aa 2023103015003052659_j_jbcpp-2015-0080_ref_027_w2aab2b8c35b1b7b1ab2ac27Aa 2023103015003052659_j_jbcpp-2015-0080_ref_010_w2aab2b8c35b1b7b1ab2ac10Aa 2023103015003052659_j_jbcpp-2015-0080_ref_041_w2aab2b8c35b1b7b1ab2ac41Aa 2023103015003052659_j_jbcpp-2015-0080_ref_023_w2aab2b8c35b1b7b1ab2ac23Aa 2023103015003052659_j_jbcpp-2015-0080_ref_032_w2aab2b8c35b1b7b1ab2ac32Aa 2023103015003052659_j_jbcpp-2015-0080_ref_006_w2aab2b8c35b1b7b1ab2ab6Aa 2023103015003052659_j_jbcpp-2015-0080_ref_044_w2aab2b8c35b1b7b1ab2ac44Aa 2023103015003052659_j_jbcpp-2015-0080_ref_035_w2aab2b8c35b1b7b1ab2ac35Aa 2023103015003052659_j_jbcpp-2015-0080_ref_017_w2aab2b8c35b1b7b1ab2ac17Aa 2023103015003052659_j_jbcpp-2015-0080_ref_026_w2aab2b8c35b1b7b1ab2ac26Aa 2023103015003052659_j_jbcpp-2015-0080_ref_039_w2aab2b8c35b1b7b1ab2ac39Aa 2023103015003052659_j_jbcpp-2015-0080_ref_001_w2aab2b8c35b1b7b1ab2ab1Aa 2023103015003052659_j_jbcpp-2015-0080_ref_040_w2aab2b8c35b1b7b1ab2ac40Aa 2023103015003052659_j_jbcpp-2015-0080_ref_022_w2aab2b8c35b1b7b1ab2ac22Aa 2023103015003052659_j_jbcpp-2015-0080_ref_031_w2aab2b8c35b1b7b1ab2ac31Aa 2023103015003052659_j_jbcpp-2015-0080_ref_013_w2aab2b8c35b1b7b1ab2ac13Aa 2023103015003052659_j_jbcpp-2015-0080_ref_043_w2aab2b8c35b1b7b1ab2ac43Aa 2023103015003052659_j_jbcpp-2015-0080_ref_034_w2aab2b8c35b1b7b1ab2ac34Aa 2023103015003052659_j_jbcpp-2015-0080_ref_016_w2aab2b8c35b1b7b1ab2ac16Aa 2023103015003052659_j_jbcpp-2015-0080_ref_025_w2aab2b8c35b1b7b1ab2ac25Aa 2023103015003052659_j_jbcpp-2015-0080_ref_009_w2aab2b8c35b1b7b1ab2ab9Aa 2023103015003052659_j_jbcpp-2015-0080_ref_038_w2aab2b8c35b1b7b1ab2ac38Aa 2023103015003052659_j_jbcpp-2015-0080_ref_029_w2aab2b8c35b1b7b1ab2ac29Aa 2023103015003052659_j_jbcpp-2015-0080_ref_005_w2aab2b8c35b1b7b1ab2ab5Aa 2023103015003052659_j_jbcpp-2015-0080_ref_002_w2aab2b8c35b1b7b1ab2ab2Aa 2023103015003052659_j_jbcpp-2015-0080_ref_021_w2aab2b8c35b1b7b1ab2ac21Aa 2023103015003052659_j_jbcpp-2015-0080_ref_030_w2aab2b8c35b1b7b1ab2ac30Aa 2023103015003052659_j_jbcpp-2015-0080_ref_012_w2aab2b8c35b1b7b1ab2ac12Aa |
| References_xml | – volume: 50 start-page: 83 year: 1995 end-page: 90 ident: j_jbcpp-2015-0080_ref_010 article-title: Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors publication-title: Biochem Pharmacol contributor: fullname: Mechoulam, R; Ben-Shabat, S; Hanus, L; Ligumsky, M; Kaminski, NE; Schatz, AR – volume: 9 start-page: e89566 year: 2014 ident: j_jbcpp-2015-0080_ref_003 article-title: Care and feeding of the endocannabinoid system: a systematic review of potential clinical interventions that upregulate the endocannabinoid system publication-title: PLoS One contributor: fullname: McPartland, JM; Guy, GW; Di Marzo, V – volume: 58 start-page: 389 year: 2006 end-page: 462 ident: j_jbcpp-2015-0080_ref_004 article-title: The endocannabinoid system as an emerging target of pharmacotherapy publication-title: Pharmacol Rev contributor: fullname: Pacher, P; Batkai, S; Kunos, G – volume: 71 start-page: 255 year: 2013 end-page: 63 ident: j_jbcpp-2015-0080_ref_040 article-title: A role for O-1602 and G protein-coupled receptor GPR55 in the control of colonic motility in mice publication-title: Neuropharmacology contributor: fullname: Li, K; Fichna, J; Schicho, R; Saur, D; Bashashati, M; Mackie, K – volume: 82 start-page: 380 year: 2011 end-page: 8 ident: j_jbcpp-2015-0080_ref_044 article-title: Endocannabinoids inhibit release of nerve growth factor by inflammation-activated mast cells publication-title: Biochem Pharmacol contributor: fullname: Cantarella, G; Scollo, M; Lempereur, L; Saccani-Jotti, G; Basile, F; Bernardini, R – volume: 126 start-page: 301 year: 2010 end-page: 13 ident: j_jbcpp-2015-0080_ref_035 article-title: Pharmacological characterization of GPR55, a putative cannabinoid receptor publication-title: Pharmacol Ther contributor: fullname: Sharir, H; Abood, ME – volume: 66 start-page: 93 year: 2002 end-page: 9 ident: j_jbcpp-2015-0080_ref_008 article-title: Discovery of endocannabinoids and some random thoughts on their possible roles in neuroprotection and aggression publication-title: Prostaglandins Leukot Essent Fatty Acids contributor: fullname: Mechoulam, R – volume: 258 start-page: 1946 year: 1992 end-page: 9 ident: j_jbcpp-2015-0080_ref_009 article-title: Isolation and structure of a brain constituent that binds to the cannabinoid receptor publication-title: Science contributor: fullname: Devane, WA; Hanus, L; Breuer, A; Pertwee, RG; Stevenson, LA; Griffin, G – volume: 51 start-page: 7327 year: 2008 end-page: 43 ident: j_jbcpp-2015-0080_ref_016 article-title: Discovery and development of fatty acid amide hydrolase (FAAH) inhibitors publication-title: J Med Chem contributor: fullname: Seierstad, M; Breitenbucher, JG – volume: 284 start-page: 29817 year: 2009 end-page: 27 ident: j_jbcpp-2015-0080_ref_034 article-title: Atypical responsiveness of the orphan receptor GPR55 to cannabinoid ligands publication-title: J Biol Chem contributor: fullname: Kapur, A; Zhao, P; Sharir, H; Bai, Y; Caron, MG; Barak, LS – volume: 287 start-page: 44234 year: 2012 end-page: 48 ident: j_jbcpp-2015-0080_ref_036 article-title: The cannabinoid receptor CB1 modulates the signaling properties of the lysophosphatidylinositol receptor GPR55 publication-title: J Biol Chem contributor: fullname: Kargl, J; Balenga, N; Parzmair, GP; Brown, AJ; Heinemann, A; Waldhoer, M – volume: 272 start-page: 27218 year: 1997 end-page: 23 ident: j_jbcpp-2015-0080_ref_014 article-title: cDNA cloning, tissue distribution, and identification of the catalytic triad of monoglyceride lipase. Evolutionary relationship to esterases, lysophospholipases, and haloperoxidases publication-title: J Biol Chem contributor: fullname: Karlsson, M; Contreras, JA; Hellman, U; Tornqvist, H; Holm, C – volume: 12 start-page: 653 year: 2012 end-page: 8 ident: j_jbcpp-2015-0080_ref_039 article-title: A potential role for GPR55 in gastrointestinal functions publication-title: Curr Opin Pharmacol contributor: fullname: Schicho, R; Storr, M – volume: 13 start-page: 321 year: 2009 end-page: 31 ident: j_jbcpp-2015-0080_ref_001 article-title: From endocannabinoid profiling to endocannabinoid therapeutics publication-title: Curr Opin Chem Biol contributor: fullname: Ligresti, A; Petrosino, S; Di Marzo, V – volume: 23 start-page: 862 year: 2011 end-page: e342 ident: j_jbcpp-2015-0080_ref_041 article-title: A novel CB receptor GPR55 and its ligands are involved in regulation of gut movement in rodents publication-title: Neurogastroenterol Motil contributor: fullname: Lin, XH; Yuece, B; Li, YY; Feng, YJ; Feng, JY; Yu, LY – volume: 60 start-page: 77 year: 2009 end-page: 84 ident: j_jbcpp-2015-0080_ref_002 article-title: The endocannabinoid system: its general strategy of action, tools for its pharmacological manipulation and potential therapeutic exploitation publication-title: Pharmacol Res contributor: fullname: Di Marzo, V – volume: 160 start-page: 604 year: 2010 end-page: 14 ident: j_jbcpp-2015-0080_ref_033 article-title: GPR55 ligands promote receptor coupling to multiple signalling pathways publication-title: Br J Pharmacol contributor: fullname: Henstridge, CM; Balenga, NA; Schröder, R; Kargl, JK; Platzer, W; Martini, L – volume: 153 start-page: 309 year: 2008 end-page: 18 ident: j_jbcpp-2015-0080_ref_021 article-title: The peripheral cannabinoid receptor knockout mice: an update publication-title: Br J Pharmacol contributor: fullname: Buckley, NE – volume: 171 start-page: 5387 year: 2014 end-page: 406 ident: j_jbcpp-2015-0080_ref_038 article-title: Heteromerization of GPR55 and cannabinoid CB2 receptors modulates signalling publication-title: Br J Pharmacol contributor: fullname: Balenga, NA; Martínez-Pinilla, E; Kargl, J; Schröder, R; Peinhaupt, M; Platzer, W – volume: 172 start-page: 142 year: 2015 end-page: 58 ident: j_jbcpp-2015-0080_ref_046 article-title: Palmitoylethanolamide, a naturally occurring lipid, is an orally effective intestinal anti-inflammatory agent publication-title: Br J Pharmacol contributor: fullname: Borrelli, F; Romano, B; Petrosino, S; Pagano, E; Capasso, R; Coppola, D – volume: 164 start-page: 131 year: 2011 end-page: 43 ident: j_jbcpp-2015-0080_ref_031 article-title: Lipid bilayer molecular dynamics study of lipid-derived agonists of the putative cannabinoid receptor, GPR55 publication-title: Chem Phys Lipids contributor: fullname: Kotsikorou, E; Lynch, DL; Abood, ME; Reggio, PH – volume: 30 start-page: 156 year: 2009 end-page: 63 ident: j_jbcpp-2015-0080_ref_032 article-title: The enigmatic pharmacology of GPR55 publication-title: Trends Pharmacol Sci contributor: fullname: Ross, RA – volume: 139 start-page: 225 year: 2008 end-page: 36 ident: j_jbcpp-2015-0080_ref_042 article-title: The putative cannabinoid receptor GPR55 plays a role in mechanical hyperalgesia associated with inflammatory and neuropathic pain publication-title: Pain contributor: fullname: Staton, PC; Hatcher, JP; Walker, DJ; Morrison, AD; Shapland, EM; Hughes, JP – volume: 25 start-page: 1835 year: 2011 end-page: 48 ident: j_jbcpp-2015-0080_ref_026 article-title: Minireview: recent developments in the physiology and pathology of the lysophosphatidylinositol-sensitive receptor GPR55 publication-title: Mol Endocrinol contributor: fullname: Henstridge, CM; Balenga, NA; Kargl, J; Andradas, C; Brown, AJ; Irving, A – volume: 384 start-page: 83 year: 1996 end-page: 7 ident: j_jbcpp-2015-0080_ref_013 article-title: Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides publication-title: Nature contributor: fullname: Cravatt, BF; Giang, DK; Mayfield, SP; Boger, DL; Lerner, RA; Gilula, NB – volume: 289 start-page: 21960 year: 2014 end-page: 72 ident: j_jbcpp-2015-0080_ref_037 article-title: Targeting CB2-GPR55 receptor heteromers modulates cancer cell signaling publication-title: J Biol Chem contributor: fullname: Moreno, E; Andradas, C; Medrano, M; Caffarel, MM; Pérez-Gómez, E; Blasco-Benito, S – volume: 86 start-page: 1646 year: 1964 end-page: 7 ident: j_jbcpp-2015-0080_ref_007 article-title: Isolation, structure and partial synthesis of an active constituent of hashish publication-title: J Am Chem Soc contributor: fullname: Gaoni, Y; Mechoulam, R – volume: 365 start-page: 61 year: 1993 end-page: 5 ident: j_jbcpp-2015-0080_ref_019 article-title: Molecular characterization of a peripheral receptor for cannabinoids publication-title: Nature contributor: fullname: Munro, S; Thomas, KL; Abu-Shaar, M – volume: 279 start-page: 5298 year: 2004 end-page: 305 ident: j_jbcpp-2015-0080_ref_011 article-title: Molecular characterization of a phospholipase D generating anandamide and its congeners publication-title: J Biol Chem contributor: fullname: Okamoto, Y; Morishita, J; Tsuboi, K; Tonai, T; Ueda, N – volume: 163 start-page: 463 year: 2003 end-page: 8 ident: j_jbcpp-2015-0080_ref_012 article-title: Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain publication-title: J Cell Biol contributor: fullname: Bisogno, T; Howell, F; Williams, G; Minassi, A; Cascio, MG; Ligresti, A – volume: 83 start-page: 393 year: 1998 end-page: 411 ident: j_jbcpp-2015-0080_ref_020 article-title: Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system publication-title: Neuroscience contributor: fullname: Tsou, K; Brown, S; Sañudo-Peña, MC; Mackie, K; Walker, JM – volume: 30 start-page: S13 year: 2006 end-page: 8 ident: j_jbcpp-2015-0080_ref_006 article-title: The pharmacology of cannabinoid receptors and their ligands: an overview publication-title: Int J Obes (Lond) contributor: fullname: Pertwee, RG – volume: 346 start-page: 561 year: 1990 end-page: 4 ident: j_jbcpp-2015-0080_ref_018 article-title: Structure of a cannabinoid receptor and functional expression of the cloned cDNA publication-title: Nature contributor: fullname: Matsuda, LA; Lolait, SJ; Brownstein, MJ; Young, AC; Bonner, TI – volume: 32 start-page: 265 year: 2011 end-page: 9 ident: j_jbcpp-2015-0080_ref_027 article-title: L-α-lysophosphatidylinositol meets GPR55: a deadly relationship publication-title: Trends Pharmacol Sci contributor: fullname: Ross, RA – volume: 21 start-page: 1452 year: 2011 end-page: 69 ident: j_jbcpp-2015-0080_ref_043 article-title: GPR55 regulates cannabinoid 2 receptor-mediated responses in human neutrophils publication-title: Cell Res contributor: fullname: Balenga, NA; Aflaki, E; Kargl, J; Platzer, W; Schröder, R; Blättermann, S – volume: 5 start-page: 37 year: 2009 end-page: 44 ident: j_jbcpp-2015-0080_ref_015 article-title: Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects publication-title: Nat Chem Biol contributor: fullname: Long, JZ; Li, W; Booker, L; Burston, JJ; Kinsey, SG; Schlosburg, JE – volume: 145 start-page: 13 year: 2009 end-page: 20 ident: j_jbcpp-2015-0080_ref_028 article-title: 2-Arachidonoyl-sn-glycero-3-phosphoinositol: a possible natural ligand for GPR55 publication-title: J Biochem contributor: fullname: Oka, S; Toshida, T; Maruyama, K; Nakajima, K; Yamashita, A; Sugiura, T – volume: 27 start-page: 153 year: 2015 end-page: 60 ident: j_jbcpp-2015-0080_ref_045 article-title: The differential characterization of GPR55 receptor in human peripheral blood reveals a distinctive expression in monocytes and NK cells and a proinflammatory role in these innate cells publication-title: Int Immunol contributor: fullname: Chiurchiù, V; Lanuti, M; De Bardi, M; Battistini, L; Maccarrone, M – volume: 56 start-page: 4798 year: 2013 end-page: 810 ident: j_jbcpp-2015-0080_ref_030 article-title: Nieger M, Bräse S, Müller CE. Antagonists for the orphan G-protein-coupled receptor GPR55 based on a coumarin scaffold publication-title: J Med Chem contributor: fullname: Rempel, V; Volz, N; Gläser, F – volume: 64 start-page: 193 year: 1999 end-page: 8 ident: j_jbcpp-2015-0080_ref_025 article-title: Identification and cloning of three novel human G protein-coupled receptor genes GPR52, PsiGPR53 and GPR55: GPR55 is extensively expressed in human brain publication-title: Mol Brain Res contributor: fullname: Sawzdargo, M; Nguyen, T; Lee, DK; Lynch, KR; Cheng, R; Heng, HHQ – volume: 23 start-page: 183 year: 2009 end-page: 93 ident: j_jbcpp-2015-0080_ref_029 article-title: The GPR55 ligand L-alpha-lysophosphatidylinositol promotes RhoA-dependent Ca2+ signaling and NFAT activation publication-title: FASEB J contributor: fullname: Henstridge, CM; Balenga, NA; Ford, LA; Ross, RA; Waldhoer, M; Irving, AJ – volume: 152 start-page: 1092 year: 2007 end-page: 101 ident: j_jbcpp-2015-0080_ref_024 article-title: The orphan receptor GPR55 is a novel cannabinoid receptor publication-title: Br J Pharmacol contributor: fullname: Ryberg, E; Larsson, N; Sjögren, S; Hjorth, S; Hermansson, NO; Leonova, J – volume: 34 start-page: 605 year: 1988 end-page: 13 ident: j_jbcpp-2015-0080_ref_017 article-title: Determination and characterization of a cannabinoid receptor in rat brain publication-title: Mol Pharmacol contributor: fullname: Devane, WA; Dysarz, FA 3rd; Johnson, MR; Melvin, LS; Howlett, AC – volume: 54 start-page: 161 year: 2002 end-page: 202 ident: j_jbcpp-2015-0080_ref_022 article-title: International Union of Pharmacology. XXVII. Classification of cannabinoid receptors publication-title: Pharmacol Rev contributor: fullname: Howlett, AC; Barth, F; Bonner, TI; Cabral, G; Casellas, P; Devane, WA – volume: 6 start-page: 9 year: 2012 ident: j_jbcpp-2015-0080_ref_005 article-title: The endocannabinoid system: an overview publication-title: Front Behav Neurosci contributor: fullname: Battista, N; Di Tommaso, M; Bari, M; Maccarrone, M – volume: 106 start-page: 133 year: 2005 end-page: 145 ident: j_jbcpp-2015-0080_ref_023 article-title: Evidence for novel cannabinoid receptors publication-title: Pharmacol Ther contributor: fullname: Begg, M; Pacher, P; Bátkai, S; Osei-Hyiaman, D; Offertáler, L; Mo, FM – ident: 2023103015003052659_j_jbcpp-2015-0080_ref_026_w2aab2b8c35b1b7b1ab2ac26Aa doi: 10.1210/me.2011-1197 – ident: 2023103015003052659_j_jbcpp-2015-0080_ref_028_w2aab2b8c35b1b7b1ab2ac28Aa doi: 10.1093/jb/mvn136 – ident: 2023103015003052659_j_jbcpp-2015-0080_ref_041_w2aab2b8c35b1b7b1ab2ac41Aa doi: 10.1111/j.1365-2982.2011.01742.x – ident: 2023103015003052659_j_jbcpp-2015-0080_ref_025_w2aab2b8c35b1b7b1ab2ac25Aa doi: 10.1016/S0169-328X(98)00277-0 – ident: 2023103015003052659_j_jbcpp-2015-0080_ref_024_w2aab2b8c35b1b7b1ab2ac24Aa doi: 10.1038/sj.bjp.0707460 – ident: 2023103015003052659_j_jbcpp-2015-0080_ref_012_w2aab2b8c35b1b7b1ab2ac12Aa doi: 10.1083/jcb.200305129 – ident: 2023103015003052659_j_jbcpp-2015-0080_ref_005_w2aab2b8c35b1b7b1ab2ab5Aa doi: 10.3389/fnbeh.2012.00009 – ident: 2023103015003052659_j_jbcpp-2015-0080_ref_037_w2aab2b8c35b1b7b1ab2ac37Aa doi: 10.1074/jbc.M114.561761 – ident: 2023103015003052659_j_jbcpp-2015-0080_ref_027_w2aab2b8c35b1b7b1ab2ac27Aa doi: 10.1016/j.tips.2011.01.005 – ident: 2023103015003052659_j_jbcpp-2015-0080_ref_021_w2aab2b8c35b1b7b1ab2ac21Aa doi: 10.1038/sj.bjp.0707527 – ident: 2023103015003052659_j_jbcpp-2015-0080_ref_032_w2aab2b8c35b1b7b1ab2ac32Aa doi: 10.1016/j.tips.2008.12.004 – ident: 2023103015003052659_j_jbcpp-2015-0080_ref_046_w2aab2b8c35b1b7b1ab2ac46Aa doi: 10.1111/bph.12907 – ident: 2023103015003052659_j_jbcpp-2015-0080_ref_039_w2aab2b8c35b1b7b1ab2ac39Aa doi: 10.1016/j.coph.2012.09.009 – ident: 2023103015003052659_j_jbcpp-2015-0080_ref_023_w2aab2b8c35b1b7b1ab2ac23Aa doi: 10.1016/j.pharmthera.2004.11.005 – ident: 2023103015003052659_j_jbcpp-2015-0080_ref_019_w2aab2b8c35b1b7b1ab2ac19Aa doi: 10.1038/365061a0 – ident: 2023103015003052659_j_jbcpp-2015-0080_ref_034_w2aab2b8c35b1b7b1ab2ac34Aa doi: 10.1074/jbc.M109.050187 – ident: 2023103015003052659_j_jbcpp-2015-0080_ref_043_w2aab2b8c35b1b7b1ab2ac43Aa doi: 10.1038/cr.2011.60 – ident: 2023103015003052659_j_jbcpp-2015-0080_ref_013_w2aab2b8c35b1b7b1ab2ac13Aa doi: 10.1038/384083a0 – ident: 2023103015003052659_j_jbcpp-2015-0080_ref_016_w2aab2b8c35b1b7b1ab2ac16Aa doi: 10.1021/jm800311k – ident: 2023103015003052659_j_jbcpp-2015-0080_ref_033_w2aab2b8c35b1b7b1ab2ac33Aa doi: 10.1111/j.1476-5381.2009.00625.x – ident: 2023103015003052659_j_jbcpp-2015-0080_ref_040_w2aab2b8c35b1b7b1ab2ac40Aa doi: 10.1016/j.neuropharm.2013.03.029 – ident: 2023103015003052659_j_jbcpp-2015-0080_ref_044_w2aab2b8c35b1b7b1ab2ac44Aa doi: 10.1016/j.bcp.2011.05.004 – ident: 2023103015003052659_j_jbcpp-2015-0080_ref_003_w2aab2b8c35b1b7b1ab2ab3Aa doi: 10.1371/journal.pone.0089566 – ident: 2023103015003052659_j_jbcpp-2015-0080_ref_010_w2aab2b8c35b1b7b1ab2ac10Aa doi: 10.1016/0006-2952(95)00109-D – ident: 2023103015003052659_j_jbcpp-2015-0080_ref_045_w2aab2b8c35b1b7b1ab2ac45Aa doi: 10.1093/intimm/dxu097 – ident: 2023103015003052659_j_jbcpp-2015-0080_ref_018_w2aab2b8c35b1b7b1ab2ac18Aa doi: 10.1038/346561a0 – ident: 2023103015003052659_j_jbcpp-2015-0080_ref_020_w2aab2b8c35b1b7b1ab2ac20Aa doi: 10.1016/S0306-4522(97)00436-3 – ident: 2023103015003052659_j_jbcpp-2015-0080_ref_002_w2aab2b8c35b1b7b1ab2ab2Aa doi: 10.1016/j.phrs.2009.02.010 – ident: 2023103015003052659_j_jbcpp-2015-0080_ref_022_w2aab2b8c35b1b7b1ab2ac22Aa doi: 10.1124/pr.54.2.161 – ident: 2023103015003052659_j_jbcpp-2015-0080_ref_029_w2aab2b8c35b1b7b1ab2ac29Aa doi: 10.1096/fj.08-108670 – ident: 2023103015003052659_j_jbcpp-2015-0080_ref_006_w2aab2b8c35b1b7b1ab2ab6Aa doi: 10.1038/sj.ijo.0803272 – ident: 2023103015003052659_j_jbcpp-2015-0080_ref_001_w2aab2b8c35b1b7b1ab2ab1Aa doi: 10.1016/j.cbpa.2009.04.615 – ident: 2023103015003052659_j_jbcpp-2015-0080_ref_007_w2aab2b8c35b1b7b1ab2ab7Aa doi: 10.1021/ja01062a046 – ident: 2023103015003052659_j_jbcpp-2015-0080_ref_009_w2aab2b8c35b1b7b1ab2ab9Aa doi: 10.1126/science.1470919 – ident: 2023103015003052659_j_jbcpp-2015-0080_ref_042_w2aab2b8c35b1b7b1ab2ac42Aa doi: 10.1016/j.pain.2008.04.006 – ident: 2023103015003052659_j_jbcpp-2015-0080_ref_011_w2aab2b8c35b1b7b1ab2ac11Aa doi: 10.1074/jbc.M306642200 – ident: 2023103015003052659_j_jbcpp-2015-0080_ref_035_w2aab2b8c35b1b7b1ab2ac35Aa doi: 10.1016/j.pharmthera.2010.02.004 – ident: 2023103015003052659_j_jbcpp-2015-0080_ref_015_w2aab2b8c35b1b7b1ab2ac15Aa doi: 10.1038/nchembio.129 – ident: 2023103015003052659_j_jbcpp-2015-0080_ref_038_w2aab2b8c35b1b7b1ab2ac38Aa doi: 10.1111/bph.12850 – ident: 2023103015003052659_j_jbcpp-2015-0080_ref_008_w2aab2b8c35b1b7b1ab2ab8Aa doi: 10.1054/plef.2001.0340 – ident: 2023103015003052659_j_jbcpp-2015-0080_ref_017_w2aab2b8c35b1b7b1ab2ac17Aa – ident: 2023103015003052659_j_jbcpp-2015-0080_ref_031_w2aab2b8c35b1b7b1ab2ac31Aa doi: 10.1016/j.chemphyslip.2010.12.003 – ident: 2023103015003052659_j_jbcpp-2015-0080_ref_014_w2aab2b8c35b1b7b1ab2ac14Aa doi: 10.1074/jbc.272.43.27218 – ident: 2023103015003052659_j_jbcpp-2015-0080_ref_004_w2aab2b8c35b1b7b1ab2ab4Aa doi: 10.1124/pr.58.3.2 – ident: 2023103015003052659_j_jbcpp-2015-0080_ref_030_w2aab2b8c35b1b7b1ab2ac30Aa doi: 10.1021/jm4005175 – ident: 2023103015003052659_j_jbcpp-2015-0080_ref_036_w2aab2b8c35b1b7b1ab2ac36Aa doi: 10.1074/jbc.M112.364109 |
| SSID | ssj0000491579 |
| Score | 2.3819816 |
| SecondaryResourceType | review_article |
| Snippet | G protein-coupled receptor 55 (GPR55) shares numerous cannabinoid ligands with CB1 and CB2 receptors despite low homology with those classical cannabinoid... Abstract G protein-coupled receptor 55 (GPR55) shares numerous cannabinoid ligands with CB1 and CB2 receptors despite low homology with those classical... |
| SourceID | proquest crossref walterdegruyter |
| SourceType | Aggregation Database Publisher |
| StartPage | 297 |
| SubjectTerms | CB2 endocannabinoid system GPR55 immune modulation inflammation sepsis |
| Title | GPR55 – a putative “type 3” cannabinoid receptor in inflammation |
| URI | http://www.degruyter.com/doi/10.1515/jbcpp-2015-0080 https://www.proquest.com/docview/1788587581 |
| Volume | 27 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NS8MwFA86L17ET5zOEYaIh4U1SZO2J79wiqCMscFuJWkTmYeu7gPZf-9L27khIvSY5vB7ycvvvZf8HkKXzChuEmmJ9GlKfKEDEiXWIzaQAU21MVHRJeL1TT4P_ZeRGFUJt1l1rXLlEwtHnU4SlyPvUIjVBJDrkN7kn8R1jXLV1aqFxjbaocyT7kpXMAp-cizAfqko5faCiBEZClGp-8Ap3vnQSZ7DKqGCeIUs5ObBtGabe19F3To179PFcr6qkxbHT3cf7VW8Ed-Vhj5AWyY7RFe9Unh62caD9TuqWRtf4d5aknp5hG6fen0hMMEK54t5ofWNWy77inkLA7iZggB5Mk4x-D-TQxiOxxl8FpZL-bTxGA27j4OHZ1L1TiAJhz1IIq2VJzWDeEAYo8CX-Fw5KZrQ40YyJZ3OmpAJY1SCmUJPB1YzzyipUg9ICT9BtWySmVOErWWamTSkSlHfWq4s84GSay65DGHX1tH1Crg4LyUyYhdaAMZxgXHsMI4dxnXUWAEbV3tlFq8tW0fyF9gbo_6eEdgXi4Kz_-c9R7vwgyzvKTZQbT5dmAvgEnPdLBZME-3cP771-t81LMcl |
| link.rule.ids | 315,783,787,12068,21400,27936,27937,31731,33756,43322,43817 |
| linkProvider | ProQuest |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NS8MwFA-6HfQifuL8DCLiYcEmadL25Bfq1G2MMcFbSdpE9NBVtyH7731pOyciQo9pDr-XvPzee8nvIXTMjOImkZZIn6bEFzogUWI9YgMZ0FQbExVdIjpd2XryH57Fc5VwG1XXKmc-sXDU6TBxOfIzCrGaAHId0vP8nbiuUa66WrXQWER1J1UFwVf96qbb639nWYD_UlEK7gURIzIUotL3gXP87E0neQ7rhAriFcKQP4-mOd9c-Swq16l5-ZhMx7NKaXEA3a6ilYo54svS1GtowWTr6KRXSk9Pm3gwf0k1auIT3JuLUk830MVdry8EJljhfDIu1L7xkcu_Yn6EAd5MQYg8fE0xeECTQyCOXzP4LCyY8nHjJnq6vRlct0jVPYEkHHYhibRWntQMIgJhjAJv4nPlxGhCjxvJlHRKa0ImjFEJhgo9HVjNPKOkSj2gJXwL1bJhZrYRtpZpZtKQKkV9a7myzAdSrrnkMoR920CnM-DivBTJiF1wARjHBcaxwzh2GDfQ3gzYuNoto3hu2waSv8D-MervGYF_sSjY-X_eQ7TUGnTacfu--7iLluFnWd5a3EO18cfE7AOzGOuDavl8AeXpyeE |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=GPR55+%E2%80%93+a+putative+%E2%80%9Ctype+3%E2%80%9D+cannabinoid+receptor+in+inflammation&rft.jtitle=Journal+of+basic+and+clinical+physiology+and+pharmacology&rft.au=Yang%2C+Hyewon&rft.au=Zhou%2C+Juan&rft.au=Lehmann%2C+Christian&rft.date=2016-05-01&rft.pub=De+Gruyter&rft.issn=0792-6855&rft.eissn=2191-0286&rft.volume=27&rft.issue=3&rft.spage=297&rft.epage=302&rft_id=info:doi/10.1515%2Fjbcpp-2015-0080&rft.externalDBID=n%2Fa&rft.externalDocID=10_1515_jbcpp_2015_0080273297 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0792-6855&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0792-6855&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0792-6855&client=summon |